Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2010 (2010), Article ID 410170, 4 pages
http://dx.doi.org/10.4061/2010/410170
Review Article

Phases 1–3 Clinical Trials Using Adult Stem Cells in Osteonecrosis and Nonunion Fractures

1Department of Rheumatology, CHU Sart Tilman, B35, 4000 Liège, Belgium
2Rheumatology and Rehabilitation Medicine Department, Erasme Hospital, Free University of Brussels, 1070 Brussels, Belgium

Received 10 May 2010; Accepted 10 October 2010

Academic Editor: Kotaro Yoshimura

Copyright © 2010 Jean-Philippe Hauzeur and Valérie Gangji. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Gaston and A. H. R. W. Simpson, “Inhibition of fracture healing,” Journal of Bone and Joint Surgery B, vol. 89, no. 12, pp. 1553–1560, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. V. Gangji and J.-P. Hauzeur, “Cellular-based therapy for osteonecrosis,” Orthopedic Clinics of North America, vol. 40, no. 2, pp. 213–221, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. O. Hayashi, Y. Katsube, M. Hirose, H. Ohgushi, and H. Ito, “Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue,” Calcified Tissue International, vol. 82, no. 3, pp. 238–247, 2008. View at Publisher · View at Google Scholar · View at PubMed
  4. Y. Tang, W. Tang, Y. Lin, J. Long, H. Wang, L. Liu, and W. Tian, “Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats,” Cell Biology International, vol. 32, no. 9, pp. 1150–1157, 2008. View at Publisher · View at Google Scholar · View at PubMed
  5. B. Y. Liu and D. W. Zhao, “Treatment for osteonecrosis of femoral head by hVEGF-165 gene modified marrow stromal stem cells under arthroscope,” Zhonghua Yi Xue Za Zhi, vol. 89, no. 37, pp. 2629–2633, 2009. View at Google Scholar
  6. P. Hernigou and F. Beaujean, “Bone marrow in patients with pseudarthrosis. A study of progenitor cells by in vitro cloning,” Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur, vol. 83, no. 1, pp. 33–40, 1997. View at Google Scholar
  7. C. Seebach, D. Henrich, R. Tewksbury, K. Wilhelm, and I. Marzi, “Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions,” Calcified Tissue International, vol. 80, no. 4, pp. 294–300, 2007. View at Publisher · View at Google Scholar · View at PubMed
  8. J. D. F. Calder, M. F. Pearse, and P. A. Revell, “The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head,” Journal of Bone and Joint Surgery B, vol. 83, no. 3, pp. 419–422, 2001. View at Google Scholar
  9. V. Gangji, J.-P. Hauzeur, A. Schoutens, M. Hinsenkamp, T. Appelboom, and D. Egrise, “Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head,” Journal of Rheumatology, vol. 30, no. 2, pp. 348–351, 2003. View at Google Scholar
  10. P. Hernigou and F. Beaujean, “Abnormalities in the bone marrow of the iliac crest in patients who have osteonecrosis secondary to corticosteroid therapy or alcohol abuse,” Journal of Bone and Joint Surgery A, vol. 79, no. 7, pp. 1047–1053, 1997. View at Google Scholar
  11. P. Hernigou, F. Beaujean, and J. C. Lambotte, “Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis,” Journal of Bone and Joint Surgery B, vol. 81, no. 2, pp. 349–355, 1999. View at Publisher · View at Google Scholar
  12. P. A. Simkin and D. J. Downey, “Hypothesis: retrograde embolization of marrow fat may cause osteonecrosis,” Journal of Rheumatology, vol. 14, no. 5, pp. 870–872, 1987. View at Google Scholar
  13. W. M. Novicoff, A. Manaswi, M. V. Hogan, S. M. Brubaker, W. M. Mihalko, and K. J. Saleh, “Critical analysis of the evidence for current technologies in bone-healing and repair,” Journal of Bone and Joint Surgery A, vol. 90, no. 1, pp. 85–91, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. J. F. Connolly and R. Shindell, “Percutaneous marrow injection for an ununited tibia,” The Nebraska Medical Journal, vol. 71, no. 4, pp. 105–107, 1986. View at Google Scholar · View at Scopus
  15. J. F. Connolly, “Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis,” Clinical Orthopaedics and Related Research, no. 355, supplement, pp. S257–S266, 1998. View at Google Scholar · View at Scopus
  16. J. H. Healey, P. A. Zimmerman, J. M. McDonnell, and J. M. Lane, “Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients,” Clinical Orthopaedics and Related Research, no. 256, pp. 280–285, 1990. View at Google Scholar · View at Scopus
  17. J. F. Connolly, R. Guse, J. Tiedeman, and R. Dehne, “Autologous marrow injection for delayed unions of the tibia: a preliminary report,” Journal of orthopaedic trauma, vol. 3, no. 4, pp. 276–282, 1989. View at Google Scholar · View at Scopus
  18. F. E. Stinchfield, B. Sankaran, and R. Samilson, “The effect of anticoagulant therapy on bone repair,” The Journal of Bone and Joint Surgery A, vol. 38, no. 2, pp. 270–282, 1956. View at Google Scholar
  19. N. K. Garg, S. Gaur, and S. Sharma, “Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture,” Acta Orthopaedica Scandinavica, vol. 64, no. 6, pp. 671–672, 1993. View at Google Scholar · View at Scopus
  20. A. Goel, S. S. Sangwan, R. C. Siwach, and A. M. Ali, “Percutaneous bone marrow grafting for the treatment of tibial non-union,” Injury, vol. 36, no. 1, pp. 203–206, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. PH. Hernigou, A. Poignard, F. Beaujean, and H. Rouard, “Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells,” Journal of Bone and Joint Surgery A, vol. 87, no. 7, pp. 1430–1437, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. S.-J. Kim, Y.-W. Shin, and Y.-W. Shin, “A multi-center, randomized, clinical study to compare the effect and safety of autologous cultured osteoblast(Ossron) injection to treat fractures,” BMC Musculoskeletal Disorders, vol. 10, article 20, 2009. View at Publisher · View at Google Scholar · View at PubMed
  23. P. Hernigou and F. Beaujean, “Treatment of osteonecrosis with autologous bone marrow grafting,” Clinical Orthopaedics and Related Research, no. 405, pp. 14–23, 2002. View at Google Scholar · View at Scopus
  24. V. Gangji, J.-P. Hauzeur, C. Matos, V. De Maertelaer, M. Toungouz, and M. Lambermont, “Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: a pilot study,” Journal of Bone and Joint Surgery A, vol. 86, no. 6, pp. 1153–1160, 2004. View at Google Scholar · View at Scopus
  25. W. F. Ji, W. H. Ding, Z. C. Ma, J. Li, and P. J. Tong, “Three-tunnels core decompression with implantation of bone marrow stromal cells (bMSCs) and decalcified bone matrix (DBM) for the treatment of early femoral head necrosis,” Zhongguo Gu Shang, vol. 21, no. 10, pp. 776–778, 2008. View at Google Scholar · View at Scopus
  26. B.-L. Wang, W. Sun, and W. Sun, “Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells,” Archives of Orthopaedic and Trauma Surgery, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus